NEW YORK (dpa-AFX) - The US analyst firm Bernstein Research has downgraded Bayer from "Outperform" to "Market-Perform" after a strategy update and lowered the price target from 50 to 27 euros. Contrary to expectations, the agrochemical and pharmaceutical company is refraining from a demerger for the time being, wrote analyst Gunther Zechmann in a study published on Thursday. This would remove a price driver./mis

Publication of the original study: 03/07/2024 / 06:08 / UTC First transmission of the original study: 03/07/2024 / 06:08 / UTC

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------